Ethics Benchmarking Bioethics International runs The Good Pharma Scorecard, a high-visibility benchmarking program that motivates pharma and life sciences companies to improve ethical practices. Sales opportunities exist in offering enhanced benchmarking services, data transparency tools, and advisory engagements to help clients raise their GPS rankings and public trust.

Strategic Partnerships Recent collaborations with Yale and the Yale Medicines Access Network indicate BEI’s openness to academic and policy partnerships. This creates opportunities to cross-sell educational programs, policy impact assessments, and stakeholder engagement services to universities, research consortia, and global health initiatives.

Patient-Centric Focus BEI emphasizes patient health, dignity, and access across the medicine lifecycle. There is a sales angle for patient advocacy groups, payer partnerships, and access programs, including consulting on patient-centric clinical trial design, transparency disclosures, and access strategies for low- and middle-income markets.

Public Speaking & Forum The Bioethics Leadership Forum and annual roundtables position BEI as a convening authority in bioethics and industry accountability. Opportunities exist to provide executive training, keynote services, event sponsorship, and tailored roundtable facilitation for pharma, biotech, and investment firms seeking thought leadership credentials.

Regulatory & Transparency Demand With demonstrated improvements in data-sharing and transparency through GPS results, BEI products align with increasing regulatory and investor emphasis on ethics and governance. Potential upsell includes governance audits, ESG/CSR reporting support, and technology-enabled disclosure platforms for real-time ethical performance metrics.